138 related articles for article (PubMed ID: 10852052)
1. [The effect of platelet-activating factor and its antagonist--BN 52021--on immune reactions in vivo in mice and in vitro].
Poveshchenko AF; Kozlov VA
Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):53-6. PubMed ID: 10852052
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
Piper PJ; Stewart AG
Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
[TBL] [Abstract][Full Text] [Related]
4. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
Jancar S; Braquet P; Sirois P
Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
Földes-Filep E; Braquet P; Filep J
Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
[TBL] [Abstract][Full Text] [Related]
6. Involvement of eicosanoids in platelet-activating factor-induced modulation of adenylyl cyclase activity in alveolar macrophages.
Beusenberg FD; van Schaik A; van Amsterdam JG; Bonta IL
J Lipid Mediat; 1991; 3(3):301-9. PubMed ID: 1663403
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei.
Grassi S; Francescangeli E; Goracci G; Pettorossi VE
J Neurophysiol; 1998 Jun; 79(6):3266-71. PubMed ID: 9636125
[TBL] [Abstract][Full Text] [Related]
8. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
Stewart AG; Dusting GJ
Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
[TBL] [Abstract][Full Text] [Related]
9. PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.
Becker K; Lueddeckens G; Grupe R; Förster W
Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):265-71. PubMed ID: 8385779
[TBL] [Abstract][Full Text] [Related]
10. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
11. The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products.
Bazan HE; Reddy ST; Woodland JM; Bazan NG
Biochem Biophys Res Commun; 1987 Dec; 149(3):915-20. PubMed ID: 2827658
[TBL] [Abstract][Full Text] [Related]
12. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three paf-acether receptor antagonist ginkgolides.
Korth R; Nunez D; Bidault J; Benveniste J
Eur J Pharmacol; 1988 Jul; 152(1-2):101-10. PubMed ID: 2850196
[TBL] [Abstract][Full Text] [Related]
14. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.
Cruzado JM; Torras J; Riera M; Lloberas N; Herrero I; Condom E; Martorell J; Alsina J; Grinyó JM
Clin Exp Immunol; 1998 Jul; 113(1):136-44. PubMed ID: 9697996
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
Hostettler ME; Knapp PE; Carlson SL
Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet-activating factor (PAF) in the initiation of the decidual reaction in the rat.
Acker G; Braquet P; Mencia-Huerta JM
J Reprod Fertil; 1989 Mar; 85(2):623-9. PubMed ID: 2703999
[TBL] [Abstract][Full Text] [Related]
17. Elvax as a slow-release delivery agent for a platelet-activating factor receptor agonist and antagonist.
Bix GJ; Clark GD
J Neurosci Methods; 1997 Nov; 77(1):67-74. PubMed ID: 9402559
[TBL] [Abstract][Full Text] [Related]
18. Desensitization of platelet-activating factor receptors, induced by inflammation in guinea pig ileal smooth muscle cells.
Jeanneton O; Delvaux M; Frexinos J; Bueno L
Gastroenterology; 1995 Jun; 108(6):1666-75. PubMed ID: 7768370
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of PAF-acether on the dog kidney.
Hébert RL; Sirois P; Braquet P; Plante GE
Prostaglandins Leukot Med; 1987 Mar; 26(3):189-202. PubMed ID: 3033688
[TBL] [Abstract][Full Text] [Related]
20. Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin.
Thielman NM; Marcinkiewicz M; Sarosiek J; Fang GD; Guerrant RL
J Clin Invest; 1997 Apr; 99(8):1999-2004. PubMed ID: 9109445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]